CX Institutional’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.71M | Sell |
30,364
-4,720
| -13% | -$1.1M | 0.22% | 111 |
|
|
2026
Q1 | $8.58M | Sell |
35,084
-30,351
| -46% | -$7.07M | 0.26% | 85 |
|
|
2025
Q4 | $13.5M | Sell |
65,435
-3,822
| -6% | -$756K | 0.4% | 50 |
|
|
2025
Q3 | $12.8M | Buy |
69,257
+5,165
| +8% | +$885K | 0.39% | 53 |
|
|
2025
Q2 | $9.79M | Buy |
64,092
+1,958
| +3% | +$301K | 0.34% | 55 |
|
|
2025
Q1 | $10.3M | Buy |
62,134
+3,821
| +7% | +$598K | 0.39% | 62 |
|
|
2024
Q4 | $8.43M | Buy |
58,313
+9,146
| +19% | +$1.42M | 0.33% | 67 |
|
|
2024
Q3 | $7.97M | Buy |
49,167
+12,856
| +35% | +$2.05M | 0.35% | 75 |
|
|
2024
Q2 | $5.31M | Sell |
36,311
-3,693
| -9% | -$549K | 0.25% | 101 |
|
|
2024
Q1 | $6.33M | Buy |
40,004
+5,333
| +15% | +$849K | 0.31% | 82 |
|
|
2023
Q4 | $5.43M | Buy |
34,671
+24
| +0.1% | +$3.68K | 0.29% | 95 |
|
|
2023
Q3 | $5.4M | Buy |
34,647
+14,192
| +69% | +$2.34M | 0.3% | 89 |
|
|
2023
Q2 | $3.39M | Buy |
20,455
+1,405
| +7% | +$227K | 0.18% | 169 |
|
|
2023
Q1 | $2.98M | Buy |
19,050
+763
| +4% | +$123K | 0.16% | 187 |
|
|
2022
Q4 | $3.23M | Buy |
18,287
+583
| +3% | +$101K | 0.2% | 150 |
|
|
2022
Q3 | $2.89M | Sell |
17,704
-11,633
| -40% | -$1.97M | 0.2% | 127 |
|
|
2022
Q2 | $5.21M | Buy |
29,337
+340
| +1% | +$60.6K | 0.39% | 60 |
|
|
2022
Q1 | $5.14M | Sell |
28,997
-2,774
| -9% | -$472K | 0.41% | 61 |
|
|
2021
Q4 | $5.43M | Sell |
31,771
-4,707
| -13% | -$771K | 0.43% | 65 |
|
|
2021
Q3 | $5.89M | Buy |
36,478
+870
| +2% | +$148K | 0.48% | 56 |
|
|
2021
Q2 | $5.87M | Sell |
35,608
-296
| -0.8% | -$49K | 0.48% | 54 |
|
|
2021
Q1 | $5.9M | Buy |
35,904
+458
| +1% | +$74.1K | 0.53% | 50 |
|
|
2020
Q4 | $5.58M | Sell |
35,446
-446
| -1% | -$65.8K | 0.54% | 47 |
|
|
2020
Q3 | $5.34M | Buy |
35,892
+21,468
| +149% | +$3.18M | 0.58% | 49 |
|
|
2020
Q2 | $2.03M | Buy |
14,424
+1,167
| +9% | +$170K | 0.27% | 97 |
|
|
2020
Q1 | $1.74M | Sell |
13,257
-7,147
| -35% | -$1.01M | 0.28% | 74 |
|
|
2019
Q4 | $2.98M | Buy |
20,404
+8,022
| +65% | +$1.09M | 0.52% | 44 |
|
|
2019
Q3 | $1.6M | Sell |
12,382
-384
| -3% | -$50.6K | 0.26% | 96 |
|
|
2019
Q2 | $1.78M | Buy |
12,766
+555
| +5% | +$76.8K | 0.28% | 86 |
|
|
2019
Q1 | $1.71M | Buy |
12,211
+1,380
| +13% | +$185K | 0.3% | 103 |
|
|
2018
Q4 | $1.4M | Buy |
10,831
+9,831
| +983% | +$1.37M | 0.3% | 78 |
|
|
2018
Q3 | $138K | Hold |
1,000
| – | – | 0.05% | 132 |
|
|
2018
Q2 | $121K | Buy |
+1,000
| New | +$125K | 0.04% | 123 |
|
Other funds holding JNJ
CX Institutional's JNJ Position: Q2 2026 in Review
CX Institutional reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $1.1M and leaving 30,364 shares worth $7.71M. The position accounts for 0.22% of the portfolio, ranked #111.
CX Institutional first reported a position in JNJ in Q2 2018 and has held it in 33 quarters since. The position peaked at $13.5M in Q4 2025. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- CX Institutional held 30,364 shares of Johnson & Johnson worth $7.71M as of Q2 2026.
- CX Institutional sold 4,720 Johnson & Johnson shares in Q2 2026, an estimated $1.1M.
- Johnson & Johnson made up 0.22% of CX Institutional's portfolio in Q2 2026, its #111 holding.
- CX Institutional first reported a position in Johnson & Johnson in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Johnson & Johnson position peaked at $13.5M in Q4 2025.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.